LAB Research Inc. Launches New Business Development Platform Following the Recent GLP Recertification of its Two European Sites and Signs Up Exclusive Agent for Japan

LAVAL, QC, Nov. 12 /CNW Telbec/ - LAB Research Inc. ("LRI" or "LAB Research") (TSX: LRI), a Canadian-based global non-clinical contract research organization ("CRO"), announces the implementation of a new Business Development platform (the "BD Platform") in Europe to leverage the recent Good Laboratory Practices ("GLP") recertification of both the Hungarian ("LAB Hungary") and Danish sites, as well as the recent expansion of these two European laboratories. LAB Research also announced that it entered into an exclusive agency agreement with Media Services, a Japan-based consulting company. Under the terms of the agreement, Media Services will represent LAB Research in Japan by targeting the large Japanese pharmaceutical market, as well as assist LAB Hungary in better serving the local agro-chemical market.